CRNX
CRNX
NASDAQ · Pharmaceuticals

Crinetics Pharmaceuticals In

$37.48
-6.01 (-13.82%)
As of May 9, 1:19 AM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +31.8% upside
Low Target $38.77
Average Target $49.40
High Target $74.88
Current Price $37.48
Current
$37.48
Target
$49.40
$38.77 $49.40 avg $74.88
Scenario Analysis
Bear Case
$38.77
3.4%
Low target
Base Case
$49.40
+31.8%
Avg target
Bull Case
$74.88
+99.8%
High target
Risk/Reward
29.0x
Highly favorable
Price in Context
52-Week High
$57.99
-35.4% from high
52-Week Low
$25.83
+45.1% from low
50-Day SMA
$49.40
-24.1% vs SMA
200-Day SMA
$38.81
-3.4% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$49.40
-14.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%